Erratum: Interobserver Agreement in Detecting Spectral-Domain Optical Coherence Tomography Features of Diabetic Macular Edema (PLoS ONE (2015) 10:5 (e0126557) doi:10.1371/journal.pone.0126557);Interobserver agreement in detecting spectral-domain optical coherence tomography features of diabetic macular edema

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Heng, Ling Zhi ^a   Pefianaki, Maria ^a   Hykin, Philip ^a   Patel, Praveen J ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; IMAGE PROCESSING; INTEROBSERVER AGREEMENT; MALE; OBSERVER VARIATION; RETINA EDEMA; RETINA FOVEA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL FLUID; CLINICAL TRIAL; DIABETIC RETINOPATHY; MACULAR EDEMA; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES;

AGED; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; OBSERVER VARIATION; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84930669160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142023     Document Type: Erratum

References (16)

1. Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology, 2010. 117(6): p. 1078-1086 e2. doi: 10.1016/j.ophtha.2010.03.045 PMID: 20416952
2. Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, et al. Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study. Ophthalmology, 2010. 117(11): p. 2146-51. doi: 10.1016/j.ophtha.2010.08.016 PMID: 20855114
3. Comyn O, Heng LZ, Ikeji F, Bibi K, Hykin PG, Bainbridge JW, et al. Repeatability of Spectralis OCT measurements of macular thickness and volume in diabetic macular edema. Investigative ophthalmology & visual science, 2012. 53(12): p. 7754-9.
4. Minassian DC, Owens DR, Reidy A. Prevalence of diabetic macular oedema and related health and social care resource use in England. The British journal of ophthalmology, 2012. 96(3): p. 345-9. doi: 10.1136/bjo.2011.204040 PMID: 21602478
5. Varma R, Bressler NM, Doan QV, Gleeson M, Danese M, Bower JK, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA ophthalmology, 2014. 132(11): p. 1334-40. doi: 10.1001/jamaophthalmol.2014.2854 PMID: 25125075
6. Wang FH, Liang YB, Zhang F, Wang JJ, Wei WB, Tao QS, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology, 2009. 116(3): p. 461-7. doi: 10.1016/j.ophtha.2008.10.003 PMID: 19168222
7. Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. Journal of clinical epidemiology, 1990. 43(6): p. 543-9. PMID: 2348207
8. Lantz CA,Nebenzahl E. Behavior and interpretation of the kappa statistic: resolution of the two paradoxes. Journal of clinical epidemiology, 1996. 49(4): p. 431-4. PMID: 8621993
9. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Family medicine, 2005. 37(5): p. 360-3. PMID: 15883903
10. Baskin DE. Optical coherence tomography in diabetic macular edema. Current opinion in ophthalmology, 2010. 21(3): p. 172-7. doi: 10.1097/ICU.0b013e32833866ae PMID: 20224402
11. Schimel AM, Fisher YL, Flynn HW JR. Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain. Ophthalmic surgery, lasers &imaging: the official journal of the International Society for Imaging in the Eye, 2011. 42 Suppl: p. S41-55.
12. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology, 2011. 118(12): p. e5-14. doi: 10.1016/j.ophtha.2011.09.058 PMID: 22136692
13. Patel PJ, Browning AC, Chen FK, Da Cruz L, Tufail A. Interobserver agreement for the detection of optical coherence tomography features of neovascular age-related macular degeneration. Investigative ophthalmology & visual science, 2009. 50(11): p. 5405-10.
14. Fiore T, Androudi S, Iaccheri B, Lupidi M, Giansanti F, Fruttini D, et al. Repeatability and reproducibility of retinal thickness measurements in diabetic patients with spectral domain optical coherence tomography. Current eye research, 2013. 38(6): p. 674-9. doi: 10.3109/02713683.2013.781191 PMID: 23520977
15. Sohn EH, Chen JJ, Lee K, Niemeijer M, Sonka M, Abràmoff MD. Reproducibility of diabetic macular edema estimates from SD-OCT is affected by the choice of image analysis algorithm. Investigative ophthalmology & visual science, 2013. 54(6): p. 4184-8.
16. Bressler SB, Edwards AR, Chalam KV, Bressler NM, Glassman AR, Jaffe GJ, et al. Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema. JAMA ophthalmology, 2014. 132(9): p. 1113-22. doi: 10.1001/jamaophthalmol.2014.1698 PMID: 25058482